文献速递神经肿瘤

美国2004-2015年原发性中枢神经系统肿瘤治疗与生存分析

Primary central nervous system tumor treatment and survival in the United States, 2004-2015.
PubMed 文献 · J Neurooncol · 2019-06-28

基于美国国家癌症数据库2004-2015年512,168例原发性中枢神经系统肿瘤记录,分析患者人口学、治疗方式及生存估计。最常见组织学为脑膜瘤(43.6%)、胶质母细胞瘤(22.0%)和神经鞘瘤(10.6%)。高龄、男性、非西班牙裔、更多合并症和较低社会经济地位是死亡风险因素。

要点

  • 脑膜瘤占比最高(43.6%),其次为胶质母细胞瘤(22.0%)和神经鞘瘤(10.6%)。
  • 高级别肿瘤最常用手术联合放化疗(WHO III级40.5%,IV级49.3%)。
  • 高龄、男性、非西班牙裔、合并症多及低社会经济地位与死亡风险相关。

核心结论

  • 该分析提供了美国中枢神经系统肿瘤的长期生存估计和初始治疗决策,年龄、合并症、性别、种族和社会经济特征是生存的决定因素。

研究设计与样本

  • 回顾性分析美国国家癌症数据库2004-2015年所有诊断为原发性中枢神经系统肿瘤的患者记录,共512,168例。

主要发现

  • 最常见组织学为脑膜瘤(43.6%),其次为胶质母细胞瘤(22.0%)和神经鞘瘤(10.6%)。
  • 患者中位年龄60岁,女性占57.9%,白人占85.0%,非西班牙裔占87.8%。
  • WHO分级:I级55.9%,II级5.9%,III级4.4%,IV级24.3%,未知或不适用9.4%。
  • 总体56%接受手术,30.4%接受放疗,20.6%接受化疗。
  • 高级别肿瘤中最常见治疗方式为放疗+化疗+手术(WHO III级40.5%,IV级49.3%),低级别肿瘤偏好手术 alone 或观察等待。

临床怎么用

  • 美国中枢神经系统肿瘤的长期生存估计和初始治疗决策模式可参考,但需结合患者个体因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Brain tumor treatment and survival information is generally limited in large-scale cancer datasets. We provide a clinical investigation of current patterns of care and survival estimates for central nervous system (CNS) tumors treated in the United States. METHODS: We analyzed the National Cancer Database from 2004-2015 for all patients with diagnosis of primary CNS tumors. We describe patient demographics, treatment modality, and analyzed survival estimates. RESULTS: 512,168 patient tumor records were examined. The most common histology was meningioma (43.6%), followed by glioblastoma (22.0%), and nerve sheath tumors (10.6%). Patients had a median age of 60 years, with a female (57.9%), white (85.0%), and non-Hispanic (87.8%) predominance. Tumors were reported as World Health Organization (WHO) grade I for 55.9% of the patients, grade II for 5.9%, grade III for 4.4%, grade IV for 24.3%, and grade unknown or not applicable for 9.4%. Overall, 56% underwent surgical procedures, 30.4% received radiation, and 20.6% received chemotherapy. Radiation plus chemotherapy and surgery was the most common treatment modality in high-grade tumors (40.5% in WHO grade III and 49.3% in WHO grade IV), while surgery only or watchful waiting was preferred in low-grade tumors. Older age, male gender, non-Hispanic origin, higher number of comorbidities, and lower socioeconomic status were identified as risk factors for mortality. CONCLUSIONS: Our analysis provides long-term survival estimates and initial treatment decisions for patients with CNS tumors in hospitals throughout the United States. Age, comorbidities, gender, ethnicity, and socioeconomic characteristics were determinants of survival.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Garcia CR, Slone SA, Dolecek TA, et al. Primary central nervous system tumor treatment and survival in the United States, 2004-2015. J Neurooncol. 2019. PMID: 31254264. doi:10.1007/s11060-019-03218-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。